Doer Biologics Completes Enrollment of the Phase 2 Clinical Study of DR10624 for Treatment of Severe Hypertriglyceridemia

HANGZHOU,China,March 10,2025-- Zhejiang Doer Biologics Co.,Ltd. ("Doer Bio"),a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and canc

China's regional powerhouses chart distinctive paths in national modernization drive

BEIJING,March 9,2025-- A report by People\'s Daily ： Chinese President Xi Jinping urged east China\'s Jiangsu province,an economic powerhouse,to play a major role in the country\'s overall developmen

CrowdStrike Awarded with Frost & Sullivan's 2024 Company of the Year Award for SaaS Security Posture Management Leadership

CrowdStrike Falcon® Shield delivers industry-leading protection and control over SaaS misconfigurations,identities and threats – unifying hybrid identity protection

ChipMOS REPORTS FEBRUARY 2025 REVENUE

HSINCHU,March 10,2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS),an industry leading provider o

Sri Lanka Unveils Landmark Fully Automated Terminal, CWIT, Powered by ZPMC's Cutting-Edge Technology

SHANGHAI,March 10,2025--On February 27,2025,Colombo West International Terminal (CWIT),Sri Lanka\'s first fully automated terminal developed with the participation of Shanghai Zhenhua Heavy Industries

Visitor pre-registration is opening now for productronica China 2025 in March

SHANGHAI,March 10,2025-- productronica China 2025will be held on March 26-28,2025 at the Shanghai New International Expo Centre(Halls E1-E5,W1-W4),with a scale of nearly 100,000 square meters and feat

Gleneagles Hospital Hong Kong pioneers transformative Histotripsy treatment for liver cancer in private sector in Asia

HONG KONG,March 10,2025-- Gleneagles Hospital Hong Kong (Gleneagles) is excited to be the first private hospital in Asia to offer Histotripsy treatment,the transformative and non-invasive technology t

Gan & Lee Pharmaceuticals Announced First Participant Dosed in the US Phase 2 Clinical Study of Bofanglutide (GZR18) Injection for Overweight or Obesity

BEIJING and BRIDGEWATER,N.J.,March 10,2025-- Gan & Lee Pharmaceuticals(Gan & Lee,Shanghai Stock Exchange: 603087) announced that the first participant has been successfully dosed in a Phase 2

AI Takes Center Stage at Beijing InfoComm China 2025 Summit

Over 70 Tech-Focused Sessions and 7 Special Events Unveiled BEIJING,March 11,2025-- Beijing InfoComm China 2025 is poised for another significantshowingat the China National Convention Center from 16-

CrowdStrike Awarded with Frost & Sullivan's 2024 Company of the Year Award for SaaS Security Posture Management Leadership

CrowdStrike Falcon® Shield delivers industry-leading protection and control over SaaS misconfigurations,identities and threats – unifying hybrid identity protection